ALMANAC

ALMANAC

ALMANAC

Add article description

This article is about the clinical trial. For other uses, see Almanac (disambiguation).

ALMANAC is a major breast cancer trial. The acronym stands for "Axillary Lymphatic Mapping Against Nodal Axillary Clearance." This major randomized trial performed in several centres in the UK produced clear evidence that sentinel node biopsy (SNB), used to stage axillary spread of disease, can be used with low failed localization and false negative rates, provided both radioisotope and blue dye are used to locate the sentinel nodes.[1]

References

  1. [1]
    Hiram S Cody (2003). Sentinel Lymph Node Biopsy. Informa Health Care. p. 237. ISBN 1-84184-034-3.


Stub icon

This oncology article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article ALMANAC, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.